Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics
Xinxin
Liu
a,
Zhongwen
Yuan
a,
Zheng
Tang
a,
Qi
Chen
a,
Jiarun
Huang
a,
Lizhen
He
*ab and
Tianfeng
Chen
*ab
aDepartment of Neurology and Stroke Center of The First Affiliated Hospital, and Department of Chemistry, Jinan University, Guangzhou 510632, China. E-mail: hlz6371@jnu.edu.cn; tchentf@jnu.edu.cn
bThe Guangzhou Key Laboratory of Molecular and Functional Imaging for Clinical Translation, Guangzhou 510632, China
First published on 29th November 2022
Abstract
Correction for ‘Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics’ by Xinxin Liu et al., Biomater. Sci., 2021, 9, 4691–4700, https://doi.org/10.1039/d1bm00348h.
The authors regret that the incorrect images were used in Fig. 1G (N2 adsorption–desorption isotherm) and in Fig. 2D (clonogenic assay of HeLa cells) in the original version of the manuscript. The corrected Fig. 1G and 2D are shown below.
 | ||
| Fig. 1 (G) N2 adsorption–desorption isotherm. | ||
 | ||
| Fig. 2 (D) HeLa cells were cultured in 6-well plates with specific concentrations of SeD@MSNs-FA and radiation (2 Gy), and a clonogenic assay was performed over 8 days. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2023 |